FDA Inspection
Trilogy Laboratories, LLCTrilogy Laboratories, LLC – FDA Inspection, Aug 27, 2019
Record Details
This FDA Inspection record concerns Trilogy Laboratories, LLC, with an inspection on August 27, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d31dd5f2-9b36-4d57-84ea-febedf1464d2
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1100500
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
- Enforcement
- Warning Letter
FDA Citations
8- 21 CFR 211.188Prepared for each batch, include complete information
- 21 CFR 211.137(a)Expiration date lacking
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.186(a)Signature and checking of records -- 2 persons
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.22(a)Lack of quality control unit
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Trilogy Laboratories, LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 24, 2026 | Not classified | Florida District Office |
Other documents for Trilogy Laboratories, LLC
- FDA Inspection 1338976 - 2026-09-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.